Blockade of CD300A enhances the ability of human NK cells to lyse hematologic malignancies.

Autor: Shuangcheng Li1,2, Tianci Wang1,2, Xinghui Xiao1,2, Xiaodong Zheng1,2, Haoyu Sun1,2, Rui Sun1,2, Hongdi Ma1,2, Zhigang Tian1,2,3,4,5 tzg@ustc.edu.cn, Xiaohu Zheng1,2,5 ustczxh@ustc.edu.cn
Zdroj: Cancer Biology & Medicine. Apr2024, Vol. 21 Issue 4, p331-346. 16p.
Databáze: Academic Search Ultimate